Previous 10 | Next 10 |
AnPac Bio-Medical Science (NASDAQ: ANPC) , a company with operations in the United States and China focused on early cancer screening and detection, received the first payment in late February 2023 from a Malaysian customer that had purchased AnPac Bio’s Model...
AnPac Bio Announces Receipt of the First Payment from a Malaysia Customer On a Signed US$1.5 Million Cancer Detection Equipment Purchase Contract PR Newswire NEW YORK , March 7, 2023 /PRNewswire/ – AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio" or the "C...
AnPac Bio (NASDAQ: ANPC) is a company with operations in the United States and China focused on early cancer screening and detection with plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian-sourced food products. The company today ann...
2023-03-06 08:51:12 ET AnPac Bio-Medical Science ( NASDAQ: ANPC ) entered into definitive investment agreements with certain accredited investors in a private placement transaction wherein the company agreed to issue and sell 16.7M newly issued Class A ordinary shares, at...
AnPac Bio-Medical Science Announces US$5 Million Private Placement PR Newswire NEW YORK , March 6, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) ("AnPac Bio," the "Company" or "we"), a company with operations in the United States and...
AnPac Bio-Medical Science (NASDAQ: ANPC) , a biotechnology company with operations in the United States and China focused on early cancer screening and detection and with plans to enter into the operation of a business-to-business (“B2B”) e-commerce food platform focused on the...
AnPac Bio Announces Positive Results from its Multi-Year and Multi-Cancer Test Follow-Up Study PR Newswire NEW YORK , Feb. 22, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. ("AnPac Bio," the "Company" or "we") (ANPC), a company with operations in ...
AnPac Bio (NASDAQ: ANPC) , a company with operations in the United States and China, is engaged in early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on the sale of Asian-sourced food products. The company today an...
AnPac Bio-Medical Science ( NASDAQ: ANPC ) has announced the closing of the acquisition of GISN, a technical solution and outsourcing consulting services provider focused on the digital, internet and Web 3 business transformation for start-ups and traditional enterprises. This acq...
AnPac Bio-Medical Science Acquires GISN (HK) LIMITED, a Technical Solution and Outsourcing Consulting Services Provider PR Newswire NEW YORK , Feb. 15, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operati...
News, Short Squeeze, Breakout and More Instantly...
AnPac Bio-Medical Science Co. Ltd. Company Name:
ANPC Stock Symbol:
NASDAQ Market:
Fresh2 Group (NASDAQ: ANPC) , formerly AnPac Bio-Medical Science Co., a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform focused on th...
Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES' PR Newswire Ticker symbol change effective at the market open May 22, 2023 NEW YORK , May 19, 2023 /PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science...
Fresh2 Group Limited (NASDAQ: ANPC) , formerly AnPac Bio-Medical Science Co., a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platform foc...